From CBC News:
An experimental obesity drug also appears to help reduce the health risks from Type 2 diabetes, researchers say.
The Sanofi-Aventis drug rimonabant, also called Acomplia, reduced risk factors for heart disease in people with Type 2 diabetes compared with those taking a placebo, European researchers report in Friday's online issue of the medical journal The Lancet. ...more
Links to the latest news in the world of pharmacy with a focus on items most relevant to Canadian pharmacists or others that are interested in Canadian pharmacies. This includes news about Canadian pharmacy seen in the mainstream media on topics such as new drug information and the international pharmacy industry.
Sunday, November 05, 2006
Obesity drug may help Type 2 diabetes
I'm not sure if I've mentioned it here before, but I am predicting that Acomplia/rimonabant will be the biggest pharmaceutical phenomenon since Viagra.
No comments:
Post a Comment